Abstract
The inhibition of protein phosphorylation is proving to be a powerful therapeutic approach to treat a number of disorders. As more protein kinase inhibitors are developed, critical issues of drug and target specificity must be addressed. While a remarkable amount of information exists for the regulation of protein kinase function, relatively little is known about the substrates they phosphorylate. Classical protein kinase substrate identification approaches have been hampered largely due to high background phosphorylation in cellular lysates and the laborious methods required identifying and purifying both the protein kinases and their substrates. Recent advances in biochemistry, bioinformatics and proteomics have addressed many of these issues. A particularly powerful method to identify direct protein kinase substrates combines standard proteomics with a unique chemical genetics approach. Identification of new protein kinase substrates by such chemical-genetic and other emerging technologies may provide the next generation of drug targets for multiple therapeutic areas.
Keywords: chemical genetics, analog sensitive kinase alleles, phosphorylation, functional proteomics, mass spectrometry
Current Proteomics
Title: Mining for Protein Kinase Substrates: Integration of Biochemistry, Genetics and Proteomics
Volume: 1 Issue: 2
Author(s): Benjamin K. Benton, Christian Rommel, Mark Velleca and Christian Pasquali
Affiliation:
Keywords: chemical genetics, analog sensitive kinase alleles, phosphorylation, functional proteomics, mass spectrometry
Abstract: The inhibition of protein phosphorylation is proving to be a powerful therapeutic approach to treat a number of disorders. As more protein kinase inhibitors are developed, critical issues of drug and target specificity must be addressed. While a remarkable amount of information exists for the regulation of protein kinase function, relatively little is known about the substrates they phosphorylate. Classical protein kinase substrate identification approaches have been hampered largely due to high background phosphorylation in cellular lysates and the laborious methods required identifying and purifying both the protein kinases and their substrates. Recent advances in biochemistry, bioinformatics and proteomics have addressed many of these issues. A particularly powerful method to identify direct protein kinase substrates combines standard proteomics with a unique chemical genetics approach. Identification of new protein kinase substrates by such chemical-genetic and other emerging technologies may provide the next generation of drug targets for multiple therapeutic areas.
Export Options
About this article
Cite this article as:
Benton K. Benjamin, Rommel Christian, Velleca Mark and Pasquali Christian, Mining for Protein Kinase Substrates: Integration of Biochemistry, Genetics and Proteomics, Current Proteomics 2004; 1 (2) . https://dx.doi.org/10.2174/1570164043379433
DOI https://dx.doi.org/10.2174/1570164043379433 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mechanisms of HIV-1 Tat Neurotoxicity via CDK5 Translocation and Hyper-Activation: Role in HIV-Associated Neurocognitive Disorders
Current HIV Research Intrinsic Disorder and Function of the HIV-1 Tat Protein
Protein & Peptide Letters Immunomodulatory Drugs: IMiDs in Acute Myeloid Leukemia (AML)
Current Drug Targets ABC Transporters and the Blood-Brain Barrier
Current Pharmaceutical Design Tetralogy of Fallot and Hypoplastic Left Heart Syndrome – Complex Clinical Phenotypes Meet Complex Genetic Networks
Current Genomics Treatment of Choroidal Neovascularization in High Myopia
Current Drug Targets Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma
Current Cancer Drug Targets Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye
Current Pharmaceutical Design Role of Class II Nuclear Receptors in Liver Carcinogenesis
Anti-Cancer Agents in Medicinal Chemistry Development of FXR, PXR and CAR Agonists and Antagonists for Treatment of Liver Disorders
Current Topics in Medicinal Chemistry Diabetic CVD – Focus on Vitamin D
Cardiovascular & Hematological Agents in Medicinal Chemistry The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies
Current Medicinal Chemistry DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer
Current Cancer Drug Targets Adhesion Molecules and Kinases Involved in γ δ T Cells Migratory Pathways:Implications for Viral and Autoimmune Diseases
Current Medicinal Chemistry Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Current Pharmaceutical Design The Role of 11Beta-Hydroxysteroid Dehydrogenase in Metabolic Disease and Therapeutic Potential of 11Beta-HSD1 Inhibitors
Current Medicinal Chemistry Depression Under the Perspective of Oxytocin
Central Nervous System Agents in Medicinal Chemistry Lifestyle Interventions for Cardiovascular Risk Reduction in Women with Breast Cancer
Current Cardiology Reviews <i>In-Silico</i> and <i>In-Vitro</i> Analysis of Human <i>SOS1</i> Protein Causing Noonan Syndrome - A Novel Approach to Explore the Molecular Pathways
Current Genomics Knocking on FXR's Door:The "Hammerhead"-Structure Series of FXRs Agonists - Amphiphilic Isoxazoles with Potent In Vitro and In Vivo Activities
Current Topics in Medicinal Chemistry